Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Algorithm Helps Detect Cancer Genes

By Biotechdaily staff writers
Posted on 14 Jun 2006
An algorithm has been developed that enhances the ability to detect cancer genes. More...
The algorithm has been applied to map tumor-suppressor genes involved in lung cancer.

Research using gene-chips found that chromosomal segments, when deleted in single or both copies of genomes in a group of cancer patients, point to locations of tumor-suppressor genes implicated in the cancer. Researchers at New York University's Courant Institute of Mathematical Sciences (New York, NY, USA) focused on automatic methods for reliable detection of these genes, their locations, and boundaries. The algorithm they developed uses data from Affymetrix (Santa Clara, CA, USA) gene-chips to pinpoint genes involved in cancer, even when the genomes have other unrelated deletions.

In order to validate their algorithm, the researchers produced a high fidelity in silico model of cancer, and checked how well they could detect the right genes, as they modified various parameters of the model. They applied the algorithm to patient data and were able to discover many genes already known in the literature, in addition to several others that were statistically significant. The algorithm may be suitable for the detection of oncogenes, which when mutated or overexpressed can promote cancer growth.

The study was conducted by Professor Bud Mishra of NYU's Courant Institute and School of Medicine (New York, NY, USA) and colleagues. The findings are to be reported in the July 2006 issue of the American Journal of Human Genetics.

Members of the New York University group, Dr. Salvatore Paxia, and Dr. Thomas Anantharaman are in the process of creating a simpler interface for the software, providing interoperability across many different chip technologies, so that it can become publicly available.



Related Links:
Courant Institute of Mathematical Sciences, NYU
School of Medicine NYU

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.